230 related articles for article (PubMed ID: 17010508)
1. Utility of fluorescence in situ hybridization as a non-invasive technique in the diagnosis of upper urinary tract urothelial carcinoma.
Marín-Aguilera M; Mengual L; Ribal MJ; Musquera M; Ars E; Villavicencio H; Algaba F; Alcaraz A
Eur Urol; 2007 Feb; 51(2):409-15; discussion 415. PubMed ID: 17010508
[TBL] [Abstract][Full Text] [Related]
2. Utility of fluorescence in situ hybridization in the diagnosis of upper urinary tract urothelial carcinoma.
Luo B; Li W; Deng CH; Zheng FF; Sun XZ; Wang DH; Dai YP
Cancer Genet Cytogenet; 2009 Mar; 189(2):93-7. PubMed ID: 19215789
[TBL] [Abstract][Full Text] [Related]
3. [Clinical utility of fluorescence in situ hybridization improves the sensitivity in the diagnosis of upper urinary tract urothelial carcinoma].
Mu DW; Zhou LQ; Ding Y; He ZS; Wang Y; He Q; Yang XY
Beijing Da Xue Xue Bao Yi Xue Ban; 2010 Aug; 42(4):381-5. PubMed ID: 20721247
[TBL] [Abstract][Full Text] [Related]
4. [Numerical aberrations of chromosomes 11 and 17 detected by fish--fluorescence in situ hybridization combined with cytology in exfoliated cells from voided urine in patients with urothelial carcinoma of the bladder].
Asali MG; Kaneti J; Manor E
Harefuah; 2007 Dec; 146(12):914-9, 1000. PubMed ID: 18254439
[TBL] [Abstract][Full Text] [Related]
5. Fluorescence in situ hybridization for detecting upper urinary tract tumors--a preliminary report.
Akkad T; Brunner A; Pallwein L; Gozzi C; Bartsch G; Mikuz G; Steiner H; Verdorfer I
Urology; 2007 Oct; 70(4):753-7. PubMed ID: 17991550
[TBL] [Abstract][Full Text] [Related]
6. Utility of a modality combining FISH and cytology in upper tract urothelial carcinoma detection in voided urine samples of Chinese patients.
Xu C; Zeng Q; Hou J; Gao L; Zhang Z; Xu W; Yang B; Sun Y
Urology; 2011 Mar; 77(3):636-41. PubMed ID: 21256577
[TBL] [Abstract][Full Text] [Related]
7. Fluorescence in situ hybridization performed on exfoliated urothelial cells in patients with transitional cell carcinoma of the bladder.
Degtyar P; Neulander E; Zirkin H; Yusim I; Douvdevani A; Mermershtain W; Kaneti J; Manor E
Urology; 2004 Feb; 63(2):398-401. PubMed ID: 14972510
[TBL] [Abstract][Full Text] [Related]
8. Fluorescence in situ hybridization assay detects upper urinary tract transitional cell carcinoma in patients with asymptomatic hematuria and negative urine cytology.
Huang WT; Li LY; Pang J; Ruan XX; Sun QP; Yang WJ; Gao X
Neoplasma; 2012; 59(4):355-60. PubMed ID: 22489689
[TBL] [Abstract][Full Text] [Related]
9. Voided urine fluorescence in situ hybridization testing for upper tract urothelial carcinoma surveillance.
Johannes JR; Nelson E; Bibbo M; Bagley DH
J Urol; 2010 Sep; 184(3):879-82. PubMed ID: 20643443
[TBL] [Abstract][Full Text] [Related]
10. Distinguishing urothelial carcinoma in the upper urinary tract from benign diseases with hematuria using FISH.
Wang J; Wu J; Peng L; Tu P; Li W; Liu L; Cheng W; Wang X; Zhou S; Shi S; Ma H; Lu G; Zhou X
Acta Cytol; 2012; 56(5):533-8. PubMed ID: 23075895
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of fluorescence in situ hybridization as an ancillary tool to urine cytology in diagnosing urothelial carcinoma.
Veeramachaneni R; Nordberg ML; Shi R; Herrera GA; Turbat-Herrera EA
Diagn Cytopathol; 2003 Jun; 28(6):301-7. PubMed ID: 12768634
[TBL] [Abstract][Full Text] [Related]
12. Utility of a multiprobe fluorescence in situ hybridization assay in the detection of superficial urothelial bladder cancer.
Marín-Aguilera M; Mengual L; Ribal MJ; Burset M; Arce Y; Ars E; Oliver A; Villavicencio H; Algaba F; Alcaraz A
Cancer Genet Cytogenet; 2007 Mar; 173(2):131-5. PubMed ID: 17321328
[TBL] [Abstract][Full Text] [Related]
13. Multitarget fluorescence in situ hybridization assay detects transitional cell carcinoma in the majority of patients with bladder cancer and atypical or negative urine cytology.
Skacel M; Fahmy M; Brainard JA; Pettay JD; Biscotti CV; Liou LS; Procop GW; Jones JS; Ulchaker J; Zippe CD; Tubbs RR
J Urol; 2003 Jun; 169(6):2101-5. PubMed ID: 12771727
[TBL] [Abstract][Full Text] [Related]
14. A comparison of cytology and fluorescence in situ hybridization for the detection of urothelial carcinoma.
Halling KC; King W; Sokolova IA; Meyer RG; Burkhardt HM; Halling AC; Cheville JC; Sebo TJ; Ramakumar S; Stewart CS; Pankratz S; O'Kane DJ; Seelig SA; Lieber MM; Jenkins RB
J Urol; 2000 Nov; 164(5):1768-75. PubMed ID: 11025767
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of upper urinary tract tumors by FISH in Chinese patients.
Shan Z; Wu P; Zheng S; Tan W; Zhou H; Zuo Y; Qi H; Zhang P; Peng H; Wang Y
Cancer Genet Cytogenet; 2010 Dec; 203(2):238-46. PubMed ID: 21156239
[TBL] [Abstract][Full Text] [Related]
16. Comparative diagnostic value of urine cytology, UBC-ELISA, and fluorescence in situ hybridization for detection of transitional cell carcinoma of urinary bladder in routine clinical practice.
May M; Hakenberg OW; Gunia S; Pohling P; Helke C; Lübbe L; Nowack R; Siegsmund M; Hoschke B
Urology; 2007 Sep; 70(3):449-53. PubMed ID: 17688921
[TBL] [Abstract][Full Text] [Related]
17. Surveillance of patients with bladder carcinoma using fluorescent in-situ hybridization on bladder washings.
Bergman J; Reznichek RC; Rajfer J
BJU Int; 2008 Jan; 101(1):26-9. PubMed ID: 17850364
[TBL] [Abstract][Full Text] [Related]
18. Utility of fluorescence
Yu J; Xiong H; Wei C; Cui Z; Jin X; Zhang J
J Cancer Res Ther; 2017; 13(4):647-650. PubMed ID: 28901308
[TBL] [Abstract][Full Text] [Related]
19. Numeric aberrations of HER-2 and chromosome 17 detected by fluorescence in situ hybridization in urine-exfoliated cells from patients with urothelial carcinoma.
Inoue T; Sato K; Tsuchiya N; Matsuura S; Iinuma M; Habuchi T; Kato T
Urology; 2004 Sep; 64(3):617-21. PubMed ID: 15351620
[TBL] [Abstract][Full Text] [Related]
20. A comparison of routine cytology and fluorescence in situ hybridization for the detection of malignant bile duct strictures.
Kipp BR; Stadheim LM; Halling SA; Pochron NL; Harmsen S; Nagorney DM; Sebo TJ; Therneau TM; Gores GJ; de Groen PC; Baron TH; Levy MJ; Halling KC; Roberts LR
Am J Gastroenterol; 2004 Sep; 99(9):1675-81. PubMed ID: 15330900
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
